article thumbnail

Competition in Healthcare is Increasing—Rapidly and Dramatically

Healthcare Success

What’s more, your highest revenue service lines are likely already facing stiff competition from all angles. . For these reasons and more, it’s imperative to identify your unique selling propositions, review them, and revise them regularly to remain competitive. .

article thumbnail

Novartis headquarters raided in Swiss competition authority's patent probe

Fierce Pharma

Novartis headquarters raided in Swiss competition authority's patent probe. Thu, 09/15/2022 - 10:15

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Merck fined $38M in Spain for hindering generic competition for NuvaRing

Fierce Pharma

Merck fined $38M in Spain for hindering generic competition for NuvaRing. kdunleavy. Tue, 10/25/2022 - 11:18

article thumbnail

Competition is on the horizon for costly narcolepsy treatments

Pharma Phorum

But increased competition is on the horizon. Competition starts to heat up. Furthermore, Molina stated Jazz “suppressed generic competition and raised the price of Xyrem 841% between 2007 and 2014.”

article thumbnail

Biogen pays $900M to resolve whistleblower's MS kickback suit as competition drags on sales

Fierce Pharma

Biogen pays $900M to resolve whistleblower's MS kickback suit as competition drags on sales. Wed, 07/20/2022 - 09:57

article thumbnail

Teva warns 'skinny label' ruling could sow 'competition-killing uncertainty' for generics

Fierce Pharma

Teva warns 'skinny label' ruling could sow 'competition-killing uncertainty' for generics. fkansteiner. Thu, 07/14/2022 - 08:57

article thumbnail

Not so fast on Revlimid's fade as Bristol Myers reports sales surprise amid generic competition

Fierce Pharma

Not so fast on Revlimid's fade as Bristol Myers reports sales surprise amid generic competition. kdunleavy. Wed, 07/27/2022 - 10:50

article thumbnail

Is the launch environment really more competitive now?

Pharma Phorum

It’s often stated – mostly without reference to data – that the environment for innovative launches is more competitive now than it ever has been. Continued competitive intensity. The post Is the launch environment really more competitive now?

article thumbnail

Promising schizophrenia drug faces tough competition

European Pharmaceutical Review

Should LY03010 receive US Food and Drug Administration (FDA) approval, Luye Pharma will need to provide solid marketing and competitive pricing to set it apart from competitors and convince payers to reimburse it.”.

article thumbnail

Biosimilar competition saves US healthcare $21 billion

European Pharmaceutical Review

Amgen’s 2022 market report has detailed how competition has driven savings across healthcare, estimating that a considerable number of biologics will be in competition with biosimilars in five to 10 years.

article thumbnail

Why you should fear the customer, not the competition

Medical Sales Guru

Medical sales representatives are often advised to target the competition. If you’re in medical sales, the competition isn’t your problem…It’s the customer! Medical sales representatives are often advised to target the competition. If you're in medical sales, the competition isn't your problem.It's As a result they fear competitors might have better products and closer relationships with accounts.

article thumbnail

Medical Sales Competition: Be Better Than the Products You Sell

MedReps

Whether it’s a similar product, prescription or piece of equipment, you need to know how to deal with medical sales competition in order to meet your sales goals. How can you deal with this competition? However, you need to go a few steps further in order to beat the competition. Remember the competition has access to the same information about their products that you do. You need to provide excellent customer service if you want to stand out from the competition.

article thumbnail

Moderna’s Covid-19 vaccine sales forecast slashed amidst strong competition

Pharmaceutical Technology

Despite this, Spikevax’s average annual sales forecast has plummeted by 23% between H1 and H2 2022 according to GlobalData’s Coronavirus Disease 2019 (COVID-19) Sector Forecast reports, due to increasing competition from Pfizer’s Comirnaty, Novavax’s Nuvaxovid, and Covid-19 therapeutics.

article thumbnail

TheracosBio Drug Approval Puts It in Competition With Blockbuster Diabetes Meds

MedCity News

The FDA approved TheracosBio’s Brenzavvy as a treatment for type 2 diabetes. But before it won a regulatory nod for controlling blood glucose in adults, it was approved at a different dose (with flavor) as a veterinary product.

article thumbnail

Medical Sales Competition: How To Win Business In Medical Device Sales

Medical Sales Authority

Medical device sales is a competitive industry. Second, it means there is fierce competition once you land a job. The competitive spirit comes alive when there is good money to be made. To truly succeed in the industry you have to understand how to beat the competition.

article thumbnail

UnitedHealth-Walmart partnership heats up U.S. Medicare provider competition

Clarivate

Either way, competition over employed providers among Medicare Advantage plans has only begun to heat up and UnitedHealth remains the plan to beat. Medicare provider competition appeared first on Clarivate.

article thumbnail

Uncovering the Hidden Role of Pharmaceutical Sales: Market Research and Competitive Analysis

Contrarian Sales Techniques

Gathering information on competitors In addition to conducting market research, sales representatives also need to be aware of the competition in the pharmaceutical industry.

article thumbnail

FTC Probes Pharma and PBM Anti-Competitive Practices

PharmExec

Takes aim at actions that limit access to lower-cost drugs, calls for revamp of M&A-impact guidelines.

article thumbnail

ESMO 2022: shrinking market for Trodelvy, with fierce ADC competition

Pharmaceutical Technology

In addition to Enhertu, Trodelvy may also experience competition from Daiichi/AstraZeneca’s anti-TROP2 ADC, datopotamab deruxtecan (dato-DXd), which is being investigated in the Phase III TROPION-Breast01 trial for previously treated HR+/HER2- patients.

article thumbnail

FDA Approval of Mirati Lung Cancer Drug Sets Stage for Competition With Amgen

MedCity News

Amgen’s Lumakras became the first FDA-approved drug that addresses the elusive KRAS mutation, but Mirati believes its newly approved therapy, Krazati, could be better.

article thumbnail

UK life science competitiveness indicators 2022: measuring what matters most?

Pharma Phorum

The latest life science competitiveness indicators (LSCIs) were published by the Office of Life Sciences (OLS) in July 2022. Indicators from the 2000s were captured in the Pharmaceutical Industry Competitiveness Task Force (PICTF) Indicators.

article thumbnail

Sanofi drops out of competitive breast cancer drug race after another trial failure

MedCity News

The move means Sanofi is out of the competitive chase to develop a so-called “oral SERD” therapy for patients with a certain type of breast cancer.

article thumbnail

How to Make Competitive Medical Sales Compensation Packages

Axxelus

It’s hard to find qualified and motivated talent these days. When new talent is found for any given role, it can be incredibly difficult to keep that talent. This is a phenomenon that is affecting virtually every industry in the wake of the COVID-19 pandemic. Sales Tips sales hiring

article thumbnail

How to Be Both Competitive and Professional in Sales

MedReps

In addition to these skills, you also need to be able to be both competitive and professional in order to meet your sales goals. Balancing Your Competitive and Professional Sides as a Sales Rep. It’s easy to mistake competitiveness for rudeness.

article thumbnail

In Medical Sales…Fear The Customer, Not The Competition

Sales Pilot Medical Sales Performance

The post In Medical Sales…Fear The Customer, Not The Competition first appeared on MEDICAL SALES TRAINING. Video

article thumbnail

UK life science competitiveness indicators 2022: measuring what matters most?

Pharma Phorum

The latest life science competitiveness indicators (LSCIs) were published by the Office of Life Sciences (OLS) in July 2022. Indicators from the 2000s were captured in the Pharmaceutical Industry Competitiveness Task Force (PICTF) Indicators.

article thumbnail

FTC Probes Pharma and PBM Anti-Competitive Practices

Pharma Leaders

Takes aim at actions that limit access to lower-cost drugs, calls for revamp of M&A-impact guidelines. Compliance Channel Posts

article thumbnail

Why TytoCare’s CEO Thinks Its New ROI-Focused Primary Care Offering Is Different Than the Competition

MedCity News

Telemedicine company TytoCare launched a new offering that promises to give providers and health plans the range of products and services needed to operate successful virtual primary care programs.

article thumbnail

FTC Challenges Abuse of FDA’s Orange Book to Block Drug Competition

Pharma Leaders

The Federal Trade Commission (FTC) has filed an amicus brief in the U.S. District Court for the District of Delaware arguing that some branded drug manufacturers have a history of using restricted distribution programs to delay the introduction of generic drugs. Compliance Channel Posts

article thumbnail

Pharmacy Focus: Independent Rx Forum- NCPA's Student Business Plan Competition

Pharmacy Times

Each year, the NCPA Annual Convention is able to showcase student business plans in a competition that correlates to a real life business plan.

article thumbnail

Pharmacy benefit managers inflate drug prices and decrease competition while consumers pay the price. Does the FTC have the medicine to fix it?

MedCity News

Many have never heard of a pharmacy benefit manager, mega-profitable companies that control what consumers pay for prescription drugs. The FTC’s new probe needs to go far to change the status quo. Daily Legal MedCity Influencers Opinion SYN Top Story

article thumbnail

Nine for 2023, part three: thriving or surviving?

Pharma Phorum

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

article thumbnail

Market Competition, All-Payer Claims Databases Found to Have Limited Impact on Hospital Costs

Pharmacy Times

Study suggests states maintaining higher health care expenditures are more attentive to price transparency initiatives and tend to adopt all-payer claims databases.

article thumbnail

Personalized Presentations Give Pharma and Med Tech Reps the Edge to Beat the Competition

MobileLocker

The post Personalized Presentations Give Pharma and Med Tech Reps the Edge to Beat the Competition appeared first on MobileLocker. Find out how some simple customization techniques can help your sales presentations connect with clients and prospects.

article thumbnail

National health plan increases competitive overlap to 70% for 900+ Medicare Advantage networks in under 12 months

Clarify Health

Medicare Advantage is expected to reach 40% penetration by 2025. By 2023, available annual profit pools will range from $11 billion to $13 ­billion, making Medicare Advantage the single biggest driver of profit growth for health care insurance providers¹.

article thumbnail

Competition vs. Collaboration in Life Sciences in a Post-COVID World

Source Explorer

[link].

article thumbnail

Pfizer and Flynn appeal £70m epilepsy drug fines in UK

Pharma Phorum

Drugmakers Pfizer and Flynn Pharma have formally launched an appeal against a £70 million ($84 million) fine levied by the UK Competition and Markets Authority (CMA) for overcharging the NHS for a widely-used epilepsy drug.

article thumbnail

Pfizer, Flynn fined £70m in resurrected epilepsy drug pricing probe

Pharma Phorum

Drugmakers Pfizer and Flynn Pharma have been fined £70 million ($84 million) by the UK Competition and Markets Authority (CMA) for overcharging the NHS for a widely-used epilepsy drug. News Sales and Marketing competition law Drug pricing epilepsy Financial Flynn Pharma Pfizer regulatory UK

article thumbnail

Canadian HCPs given digital era empowerment recommendations

Pharma Phorum

The latest market study report from the Competition Bureau has provided recommendations to health care providers (HCPs) on how to improve the ways they work within Canada’s public health system. Digital News Canada Competition Bureau digital technologies HCPs healthcare

article thumbnail

UK authority asks for director ban for Alliance Pharma CEO

Pharma Phorum

The UK Competition and Markets Authority (CMA) is seeking to disqualify Peter Butterfield, currently chief executive of Alliance Pharma, from serving as a company director. News Alliance Pharma antitrust competition NHS pricing regulatory senior management UK